Search - tctmd.com

Displaying 161 - 180 of 598

Sort: Relevancy | Date

Presentation TCT 2024

Two-Year Outcomes in the Navitor IDE Study Utilizing an Intra-Annular, Self-Expandable Transcatheter Aortic Heart Valve

Presenter: Ron Waksman

October 28, 2024

News Conference News TCT 2024

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Todd Neale

October 28, 2024

Presentation TCT 2024

Incidence, Relevance, and Prevention of New-onset LBBB and PPM Implantation After TAVR

Presenter: Amit Vora

October 28, 2024

Presentation TCT 2024

Case: New LBBB After TAVR

Presenter: Jason Bloom

October 28, 2024

Presentation TCT 2024

Post-TAVR Risk-Stratification for Conduction Disturbances

Presenter: Shmuel Chen

October 28, 2024

Presentation TCT 2024

The Optimum Short Frame Self-Expanding TAVR System (Optimum TAV)

Presenter: Jaroslaw Trebacz

October 28, 2024

Presentation TCT 2024

The DurAVR System with Biomimetic Leaflet Design: Impact on Flow Dynamics and LV Mass Regression

Presenter: Amar Krishnaswamy

October 28, 2024

Presentation TCT 2024

The Ballon Expandable Siegel TAVR System: A Low-Profile Molybdenum-Rhenium Alloy Frame Design (MIRus)

Presenter: Pradeep Yadav

October 28, 2024

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

Presentation TCT 2024

The EARLY TAVR Trial Editorial Commentary

Presenter: Bernard Prendergast

October 28, 2024

Presentation TCT 2024

The Foldax Polymeric Leaflet TAVR Systems

Presenter: Steven Yakubov

October 28, 2024

Presentation TCT 2024

The ALLOW?Study:?ALLegra?TAVR Outcomes?in the Real?World

Presenter: Ignacio Cruz Gonzalez

October 28, 2024

Presentation TCT 2024

Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: The TAVR UNLOAD Trial

Presenter: Nicolas Van Mieghem

October 28, 2024

Presentation TCT 2024

Recent EU Clinical Experiences with the ACURATE TAVR System

Presenter: Ole De Backer

October 28, 2024

Presentation TCT 2024

A Living Endogenous Patient-Specific TAVR System (GrOwnValve)

Presenter: Benjamin Rieck

October 28, 2024

Presentation TCT 2024

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

Presenter: Philippe Genereux

October 28, 2024

Presentation TCT 2024

Case: Evolving Stroke After TAVR

Presenter: Jason Bloom

October 28, 2024

Presentation TCT 2024

Incidence, Diagnosis, and Management of Evolving Strokes After TAVR

Presenter: Julia Seeger

October 28, 2024

Presentation TCT 2024

A Sensible Approach to CEP for TAVR: From Clinical Trials to Clinical Practices

Presenter: Aakriti Gupta

October 28, 2024

Presentation TCT 2024

The Young Heart Polymeric Leaflet TAVR System

Presenter: Srujana Joshi

October 28, 2024

Advertisement

Two-Year Outcomes in the Navitor IDE Study Utilizing an Intra-Annular, Self-Expandable Transcatheter Aortic Heart Valve

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Incidence, Relevance, and Prevention of New-onset LBBB and PPM Implantation After TAVR

Case: New LBBB After TAVR

Post-TAVR Risk-Stratification for Conduction Disturbances

The Optimum Short Frame Self-Expanding TAVR System (Optimum TAV)

The DurAVR System with Biomimetic Leaflet Design: Impact on Flow Dynamics and LV Mass Regression

The Ballon Expandable Siegel TAVR System: A Low-Profile Molybdenum-Rhenium Alloy Frame Design (MIRus)

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

The EARLY TAVR Trial Editorial Commentary

The Foldax Polymeric Leaflet TAVR Systems

The ALLOW?Study:?ALLegra?TAVR Outcomes?in the Real?World

Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: The TAVR UNLOAD Trial

Recent EU Clinical Experiences with the ACURATE TAVR System

A Living Endogenous Patient-Specific TAVR System (GrOwnValve)

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

Case: Evolving Stroke After TAVR

Incidence, Diagnosis, and Management of Evolving Strokes After TAVR

A Sensible Approach to CEP for TAVR: From Clinical Trials to Clinical Practices

The Young Heart Polymeric Leaflet TAVR System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content